Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil combined with remimazolam besylate for cervical conization
ChiCTR2100048855Phase 4Not yet recruiting
- Sponsor
- Xijing Hospital
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of alfentanil, remimazolam and propofol in Cervical Diseases (2 arms), sponsored by Xijing Hospital. Primary endpoints: Incidence of total adverse events in the respiratory and circulatory systems, Blood pressure and 4 more. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
alfentanilremimazolampropofol
03
Conditions
Cervical Diseases
Beyond the preview
Go deeper on ChiCTR2100048855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048855.